SNS Financial Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1557485 MINNEAPOLIS, MN

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$603,526

+$249,310 QoQ

Shares Held

4,777

+15.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,295

of 2,266 holders

Holding Since

Mar 2020

13 quarters on record

Healthcare · as of Jun 30, 2026

SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	46,863	$56,208,892
2	JNJ	Johnson & Johnson	172,754	$43,874,333
3	NVO	Novo Nordisk A S	669,858	$32,112,992
4	ABBV	AbbVie Inc.	32,457	$8,167,479
5	PFE	Pfizer Inc	167,096	$4,023,671
6	MRK	Merck & Co., Inc.	27,952	$3,591,832
7	BMY	Bristol Myers Squibb Co	36,127	$2,081,637
8	AMGN	Amgen Inc	2,842	$1,029,145

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$603,526	4,777	+15.8%	Shares	Sole	2026-08-11
2022-12-31	$354,216	4,126	+1.4%	Shares	Sole	2023-01-25
2022-09-30	$251,016	4,069	+1.0%	Shares	Defined	2022-10-12
2022-06-30	$248,907	4,027	+1.2%	Shares	Sole	2022-07-22
2022-03-31	$236,551	3,979	0.0%	Shares	Sole	2022-05-12
2021-12-31	$288,915	3,979	0.0%	Shares	Sole	2022-02-14
2021-09-30	$277,933	3,979	-1.8%	Shares	Sole	2021-11-12
2021-06-30	$278,883	4,050	+0.1%	Shares	Sole	2021-08-02
2021-03-31	$261,492	4,046	+5.0%	Shares	Sole	2021-05-12
2020-12-31	$224,592	3,855	+5.5%	Shares	Sole	2021-02-05
2020-09-30	$230,959	3,655	-0.5%	Shares	Sole	2020-11-13
2020-06-30	$282,754	3,675	-4.8%	Shares	Sole	2020-08-06
2020-03-31	$288,722	3,862	—	Shares	Defined	2020-05-07
No filing history on record for this holder in this stock.